SGLT2 Inhibitors Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN
Condition:   Immunoglobulin A Nephropathy Intervention:   Drug: Sparsentan Sponsor:   Travere Therapeutics, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2023 Category: Research Source Type: clinical trials

SGLT2 Inhibitor TrEatment iN Patients Awaiting cOronary arTery bYpass Surgery to Reduce Post-opErative AF
Conditions:   Chronic Coronary Syndrome;   Atrial Fibrillation Interventions:   Drug: Dapagliflozin 10mg Tab;   Drug: Placebo Tab Sponsors:   Region Örebro County;   Odense University Hospital;   Aarhus University Hospital;   Örebro University, Sweden;   Sahlgrenska University Hospital, Sweden;   Göteborg University;   University of Leeds;   Brigham and Women's Hospital;   Skane University Hospital;   Lo ndon School of Hygiene and Tropical Medicine;   Harvard Medical School (HMS and HSDM);   Swedish Heart Lung Foundation;   The Swedish Research Council Not yet...
Source: ClinicalTrials.gov - May 10, 2023 Category: Research Source Type: clinical trials